While the U.S. gave Huawei a 90-day reprieve, allowing American businesses to keep selling specific products to the Chinese firm, it also added more affiliates of the...Technologyread more
The attacks come after state and local ransomware attacks in New York, Louisiana, Maryland and Florida resulted in the loss of significant sums.Technologyread more
China's pursuit of the Middle East may spur growth in the Islamic finance sector.World Economyread more
Twitter and Facebook have suspended accounts believed to be tied to a state-backed disinformation campaign originating from inside China.Technologyread more
United States Steel Corp will temporarily lay off hundreds of workers at its Great Lakes facility in Michigan in coming weeks, according to a filing the steelmaker made with...US Marketsread more
The report comes as Trump in recent days has lashed out over media reports about growing recession fears.Politicsread more
Beijing will lower borrowing costs for companies, but that may not boost the economy as much as some hope.China Economyread more
Stocks are bouncing higher but could be trapped in a range longer term, until there's a resolution of the trade wars.Market Insiderread more
Stocks in Asia mostly traded higher Tuesday afternoon as minutes from the Reserve Bank of Australia's July meeting were released. The People's Bank of China also published its...Asia Marketsread more
Powell will have the opportunity if not to walk back the "midcycle" assessment then to at least provide some further explanation about what it means.Economyread more
Apple has spent more than $6 billion on original TV shows and movies for its forthcoming Apple TV+ service, according to a Financial Times report on Monday.Technologyread more
He told CNBC's "Fast Money: Halftime Report" he thought seriously about selling his stake in the drugmaker, but decided he could "fix it." Ackman's holdings have endured a dismal year, hit in particular by the stake in Valeant.
His Pershing Square Capital Management portfolio had a return of -17.5 percent this year as of April 26.
Valeant shares had lost about 9 percent Monday but cut the losses in half as Ackman spoke. He touted changes in the company's structure and leadership, like its new CEO Joseph Papa.
Ackman said he aims to create a "meaningful" turnaround for the company. He added he believes Valeant has "made appropriate changes in personnel."
Ackman noted that Valeant is not considering selling any "core" assets, despite interest from buyers.
The drugmaker on Friday filed its long-delayed annual report, helping it prevent a default on its $30 billion in debt. It pointed out misstatements that would cut some of its previously reported sales.
During a Senate hearing last week on Valeant's drug pricing, Ackman said his first priority was to make sure the company did not go bankrupt.
Many politicians have recently looked to take more action on reining in increases in the price of drugs that aren't widely available. Ackman noted that price cuts at Valeant are "absolutely" on the table.
— Reuters contributed to this report.